Back to Journals » ClinicoEconomics and Outcomes Research » Volume 3

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

Total article views   HTML views PDF downloads Totals
17,320 Dovepress* 15,802+ 3,478 19,280
PubMed Central* 1,518 762 2,280
Totals 17,320 4,240 21,560
*Since 25 January 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar